- How unknown is metastatic carcinoma to cervical lymph nodes from an unknown primary?2023 | First Faculty of Medicine
- A patient with a tumour of unknown primary origin: treatment and course of the disease2020 | Publication without faculty affiliation
- Neck metastases with unknown primary tumor. Occult carcinoma of the head and neck: Handbook for the practice2014 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up2023 | Faculty of Medicine in Pilsen
- Unknown primary locate of tumorous2003 | First Faculty of Medicine
- Long-term results of radio(chemo)therapy in metastatic carcinoma to cervical lymph nodes from an unknown primary. Adult Comorbidity Evaluation 27 score as a predictor of survival2023 | First Faculty of Medicine
- Methodology of fixing the possible location of an unknown primary tumor based on patient sex, age and selected tumor markers1996 | Faculty of Medicine in Pilsen, Central Library of Charles University
- Hepatic arterial infusion in liver tumors of unknown, uncertain or unusual primary: single-center experience2019 | Faculty of Medicine in Hradec Králové
- Use of positron emission tomography/computed tomography in the initial staging of head and neck squamous cell carcinoma: Accuracy in the evaluation of the primary site of the tumor, metastases to cervical lymph nodes, and distant metastases2022 | Third Faculty of Medicine, Central Library of Charles University, First Faculty of Medicine
- Lymph node metastasis of Merkel cell carcinoma without known cutaneous primary - case report2017 | Third Faculty of Medicine, First Faculty of Medicine, Faculty of Science
- Gastrointestinal permeability in ovarian cancer and breast cancer patients treated with paclitaxel and platinum2007 | Publication without faculty affiliation
- Gastrointestinal permeability in ovarian cancer and breast cancer patients treated with paclitaxel and platinum +12007 | Faculty of Medicine in Hradec Králové
- Gastrointestinal permeability in ovarian cancer and breast cancer patients treated with paclitaxel and platinum2007 | First Faculty of Medicine
- The ENETS Consensus Quidelines 2016 - somatostatin analogues in the treatment of neuroendocrine tumors2016 | First Faculty of Medicine
- Unexpected high serum level of CA 125 in male patient suffering from metastatic papillary carcinoma: a case report2007 | Second Faculty of Medicine
- Origin of cystic squamous cell carcinoma metastases in head and neck lymph nodes: addition of EBV testing improves diagnostic accuracy2016 | Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové
- Small RNA Sequencing Identifies a Six-MicroRNA Signature Enabling Classification of Brain Metastases According to their Origin2023 | Publication without faculty affiliation
- Expression and prognostic significance of programmed death-ligand 1 (PD-L1) in Merkel cell carcinoma2019 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Cribriform adenocarcinoma of the base of the tongue and low-grade, polymorphic adenocarcinomas of the salivary glands2011 | Faculty of Medicine in Pilsen, Third Faculty of Medicine
- Novel class of ZNF384 aberrations in acute leukemia2021 | Second Faculty of Medicine
- The pathogenesis, diagnosis, and management of metastatic tumors to the ovary: a comprehensive review2017 | Faculty of Medicine in Hradec Králové
- Primary retroperitoneal nodal endometrioid carcinoma associated with Lynch syndrome: A case report2023 | First Faculty of Medicine
- Diagnostic procedure in patients with neoplasm and malignant pleural effusion: Our experience2012 | Third Faculty of Medicine
- Anti-tumour effects of lanreotide for pancreatic and intestinal neuroendocrine tumours: the CLARINET open-label extension study2016 | First Faculty of Medicine
- Genome of helicobacter pylori and serotype of hpv detected in oropharyngeal and laryngeal cancer and chronic inflammation patients2021 | Third Faculty of Medicine, First Faculty of Medicine
- Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF-mutant melanoma (COLUMBUS): a multicentre, open-label, randomised phase 3 trial2018 | First Faculty of Medicine
- Overall survival in patients with BRAF-mutant melanoma receiving encorafenib plus binimetinib versus vemurafenib or encorafenib (COLUMBUS): a multicentre, open-label, randomised, phase 3 trial2018 | First Faculty of Medicine